How cancer cells modulate m6A levels in the MAGI3 large internal exon to trigger pPA, and how this modulation of levels impacts pPA of MAGI3 from a mechanistic standpoint, are new questions that require further investigation. The gene discussed is MAGI3; the disease is cancer.